troikaa
Excellence built on basics
Innovation -- Quality -- Services
Company

   

1983 was the year in which Troikaa was founded. Commercial activities commenced in the year 1984.

The beginnings were modest. We had a small factory and employee strength of the company was 15. Constant innovation and aggressive marketing have resulted in a steady growth for Troikaa Pharmaceuticals Ltd.

Today we can boast of an impressive corporate office at Ahmedabad, two state of the art manufacturing facilities one each at Ahmedabad & Dehradun, four marketing divisions and more than 1100 employees, including our international operations.

Troikaa has big dreams and a major expansion plan for the future. Troikaa has already acquired 65 acres of land near Ahmedabad and the first quarter of 2009 will see Troikaa beginning the process of setting up manufacturing facilities for various dosage forms at this location, as per the US FDA/UK MHRA standards. The coming year will also see the company expand its marketing network both in India as well as in international markets. “The expected expansion plan in India will bring our sales force around 2000.”

- -

The company is focused on developing Novel Drug Delivery Systems. Six patents have been filed in various areas of drug delivery. The first NDDS has been introduced in India under brand name Dynapar AQ- world’ only diclofenac which can be injected in the deltoid (arm) muscle. Dynapar AQ offer multiple benefits over the conventional diclofenac injections ( Voltarol/Voltaren) , as established by multicentric clinical trials. Dynapar AQ is ranked No2 by ORG-IMS , in India.  The No1 brand ( Voveran- Novartis) is de growing @11 % , whereas Dynapar AQ is growing @ 17 % . Dynapar AQ will soon become the No. 1 brand in diclofenac in India.

The development of the other NDDS is in progress and each of them will initially be introduced in India and made successful in the same manner as Dynapar AQ. Simultaneously, the NDDS will be licensed out to business partners across the world.

The company has entered into licensing partnerships with companies in various countries for the marketing of Dynapar AQ.